Laura A. Pike

26 papers · 739 indexed citations

Immediate Impact

2 from Science/Nature 77 hit

Sub-graph 1 of 21

Citing Papers

Colorectal cancer

2024 Hit

Chemically Modified Platforms for Better RNA Therapeutics

2024 Hit

2 intermediate papers

Works of Laura A. Pike being referenced

Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low‐dose cytosine arabinoside in elderly patients with acute myeloid leukemia

2013

Cediranib Plus FOLFOX/CAPOX Versus Placebo Plus FOLFOX/CAPOX in Patients With Previously Untreated Metastatic Colorectal Cancer: A Randomized, Double-Blind, Phase III Study (HORIZON II)

2012

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Laura A. Pike	401	313	143	123	114	26	739
Peter Gaßmann	238 0.6×	380 1.2×	111 0.8×	115 0.9×	119 1.0×	23	854
Robert V. Martinez	523 1.3×	205 0.7×	50 0.3×	78 0.6×	111 1.0×	22	888
Gerald Schmid	578 1.4×	388 1.2×	53 0.4×	78 0.6×	145 1.3×	27	889
Hitoyasu Futami	330 0.8×	420 1.3×	115 0.8×	65 0.5×	89 0.8×	41	867
Gary J. Smith	320 0.8×	153 0.5×	206 1.4×	53 0.4×	214 1.9×	41	721
Xueying Wang	243 0.6×	201 0.6×	89 0.6×	65 0.5×	125 1.1×	29	644
Carole Ferraro‐Peyret	294 0.7×	112 0.4×	59 0.4×	71 0.6×	85 0.7×	28	666
Nan‐Yung Hsu	322 0.8×	168 0.5×	228 1.6×	75 0.6×	179 1.6×	44	825
Namiko Aiba	321 0.8×	201 0.6×	78 0.5×	105 0.9×	98 0.9×	22	714
Hilal Oğuz	351 0.9×	348 1.1×	103 0.7×	36 0.3×	163 1.4×	45	802

All Works

Loading papers...